Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Polycystic Ovary Syndrome 4Prostatic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Rectal Neoplasms 1Psoriasis 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasms 1Neoplasm, Residual 1Multiple Sclerosis 1Lipid Metabolism Disorders 1Inflammation 1Healthy Subject 1Dyspareunia 1Diabetes Mellitus 1Crohn Disease 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Breast Feeding 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Aggressive Periodontitis 1

Interventions

Infliximab 3Certolizumab Pegol 3golimumab 1Vaccines 1Sutures 1Surgical Instruments 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Pneumococcal Vaccines 1Photoplethysmography 1Papillomavirus Vaccines 1Methoxsalen 1MEDI2070 1Lysine Acetyltransferase 5 1Laparoscopy 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Herpes Zoster Vaccine 1Fish Oils 1Calcium Dobesilate 1Calcitriol 1CT-P13 1Bupivacaine 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Crohn Disease × Fish Oils × Clear all
NCT02349594 2015-11-10

Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease

Radboud University Medical Center

Phase 4 Completed
6 enrolled

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡